GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Short Percentage of Float

SQI Diagnostics (FRA:XSQ) Short Percentage of Float


View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of SQI Diagnostics's Short Percentage of Float

For the Diagnostics & Research subindustry, SQI Diagnostics's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SQI Diagnostics's Short Percentage of Float Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's Short Percentage of Float falls into.


SQI Diagnostics (FRA:XSQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Short Percentage of Float
Comparable Companies
TSXV:JUMP TSX:SZLS XCNQ:VTAL NEOE:MEDV TSXV:MBI.H XCNQ:IZO TSXV:ARC TSXV:AVCR XCNQ:BUX TSXV:TELO TMO DHR IDXX XSWX:LONN IQV A ILMN SHSE:603259 MTD ICLR
Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
Website
https://www.sqidiagnostics.com
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines